Spotlight
Video

Thoughts on Keynote 427 - Single Agent Pembrolizumab

obr has 860 videos Subscribe Here

Loading........
Description: David I. Quinn, MD, explains discusses Keynote 427 for Pembrolizumab, PD-1 Inhibitor and CTLA4 with Nivolumab & Ipilimumab presented at the 2018 Annual Meeting Annual Meeting.
Shared By : obr
Posted on : 07/23/18
Added : 1 year ago
Category : Kidney Cancer